Active Ingredient(s): Macimorelin Acetate
FDA Approved: * December 20, 2017
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Macrilen Overview

Macimorelin (INN), or Macrilen (trade name) is a drug being developed by Æterna Zentaris for use in the diagnosis of adult growth hormone deficiency. Macimorelin acetate, the salt formulation, is a synthetic growth hormone secretagogue receptor agonist.[2] Macimorelin acetate is described chemically as D-Tryptophanamide, 2-methylalanyl-N-[(1R)-1-(formylamino)-2-(1H-indol-3-yl)ethyl]-acetate. As of January 2014, it was in Phase III clinical trials.[3] The ...

Read more Macrilen Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Macrilen Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Macimorelin Acetate
  • For Solution: 60mg/pouch
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Macrilen: (2 results)

Sorted by National Drug Code
  • 0169-1401 Macrilen 60 mg/mg Oral Granule, for Solution by Novo Nordisk
  • 71090-002 Macrilen 60 mg/mg Oral Granule, for Solution by Strongbridge U.S. Inc

Other drugs which contain Macimorelin Acetate or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 June 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA